Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis C virus nonstructural protein 4A (NS4A) is a small, 54-amino-acid viral polypeptide that plays a critical role in the life cycle of the Hepatitis C virus (HCV). NS4A functions primarily as an essential cofactor for the NS3 serine protease, forming the heterodimeric NS3/4A protease complex. This complex is responsible for the proteolytic cleavage of the viral polyprotein at four junctions (NS3/NS4A, NS4A/NS4B, NS4B/NS5A, and NS5A/NS5B), which is required to release functional viral proteins necessary for replication. Additionally, NS4A contains a hydrophobic N-terminal transmembrane domain that anchors the NS3/4A complex to the outer leaflet of the endoplasmic reticulum membrane, localizing the replication machinery. Beyond its role in replication, NS4A is involved in viral assembly, regulation of NS5A phosphorylation, and host immune evasion by assisting in the cleavage of host proteins like MAVS and TRIF to suppress interferon signaling. While most direct-acting antivirals (DAAs) target the NS3/4A complex as a whole (such as glecaprevir, grazoprevir, and voxilaprevir), specific NS4A inhibitors like ACH-806 (GS-9132) have been developed to disrupt the replication complex by binding directly to NS4A. However, clinical development of direct NS4A inhibitors has faced challenges such as nephrotoxicity.
Inhibition of the NS3/4A protease complex, preventing viral polyprotein processing and replication; or direct binding to NS4A to disrupt the viral replication complex.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C virus nonstructural protein 4A (NS4A) (NS4A).